| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
24,270,000 |
| Market
Cap: |
513.07(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$20.03 - $40.81 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Fulgent Genetics is a holding company. Through its subsidiaries, Co. is a technology company providing COVID-19 testing services, molecular diagnostic testing services and genetic testing designed to provide physicians and patients with clinically actionable diagnostic information to improve the quality of patient care. Co. has developed a proprietary technology platform allowing Co. to provide a test menu. Combining next generation sequencing with its technology platform, Co. performs full-gene sequencing with deletion/duplication analysis in single-gene tests; pre-established, multi-gene, disease-specific panels; and customized panels that can be tailored to meet customer needs.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
26,653 |
51,184 |
66,172 |
| Total Sell Value |
$0 |
$711,752 |
$1,535,512 |
$2,170,834 |
| Total People Sold |
0 |
3 |
3 |
4 |
| Total Sell Transactions |
0 |
4 |
16 |
32 |
| End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Kim Paul |
CFO and Treasurer |
• – – |
2022-08-17 |
4 |
S |
$48.89 |
$95,100 |
D/D |
(1,945) |
150,169 |
|
39% |
|
| Xie Jian |
President and COO |
• – – |
2022-08-03 |
4 |
D |
$62.93 |
$399,165 |
D/D |
(6,343) |
311,818 |
|
- |
|
| Kim Paul |
CFO and Treasurer |
• – – |
2022-08-03 |
4 |
D |
$62.93 |
$65,951 |
D/D |
(1,048) |
152,114 |
|
- |
|
| Nohaile Michael |
Director |
– • – |
2022-08-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
4,000 |
|
- |
|
| Bolger John C |
Director |
– • – |
2022-08-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,600 |
5,100 |
|
- |
|
| Xie Jian |
President and COO |
• – – |
2022-08-01 |
4 |
D |
$59.54 |
$51,919 |
D/D |
(872) |
318,161 |
|
- |
|
| Hsieh Ming |
President and CEO |
• • • |
2022-08-01 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
30,000 |
|
- |
|
| Marsh Linda |
Director |
– • – |
2022-08-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,600 |
5,600 |
|
- |
|
| Post Leonard E |
Director |
– • – |
2022-08-01 |
4 |
A |
$0.00 |
$0 |
D/D |
8,000 |
8,000 |
|
- |
|
| Gao Hanlin |
Chief Scientific Officer |
• – – |
2022-07-30 |
4 |
D |
$59.75 |
$5,198 |
D/D |
(87) |
855,650 |
|
- |
|
| Kim Paul |
CFO and Treasurer |
• – – |
2022-06-02 |
4 |
S |
$55.10 |
$22,867 |
D/D |
(415) |
153,162 |
|
33% |
|
| Xie Jian |
President and COO |
• – – |
2022-05-31 |
4 |
S |
$54.54 |
$36,433 |
D/D |
(668) |
319,033 |
|
31% |
|
| Bolger John C |
Director |
– • – |
2022-05-31 |
4 |
S |
$55.25 |
$62,291 |
D/D |
(1,126) |
3,500 |
|
31% |
|
| Bolger John C |
Director |
– • – |
2022-05-31 |
4 |
OE |
$3.93 |
$3,047 |
D/D |
626 |
4,313 |
|
- |
|
| Xie Jian |
President and COO |
• – – |
2022-05-19 |
4 |
S |
$58.29 |
$582,866 |
D/D |
(10,000) |
319,701 |
|
33% |
|
| Marsh Linda |
Director |
– • – |
2022-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
4,000 |
|
- |
|
| Yen Yun |
Director |
– • – |
2022-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
2,000 |
|
- |
|
| Bolger John C |
Director |
– • – |
2022-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
4,000 |
|
- |
|
| Kim Paul |
CFO and Treasurer |
• – – |
2022-05-16 |
4 |
S |
$53.38 |
$63,578 |
D/D |
(1,191) |
153,577 |
|
29% |
|
| Xie Jian |
President and COO |
• – – |
2022-05-16 |
4 |
S |
$53.38 |
$67,742 |
D/D |
(1,269) |
329,701 |
|
29% |
|
| Gao Hanlin |
Chief Scientific Officer |
• – – |
2022-05-16 |
4 |
S |
$53.38 |
$17,349 |
D/D |
(325) |
855,737 |
|
29% |
|
| Xie Jian |
President and COO |
• – – |
2022-05-01 |
4 |
D |
$54.88 |
$40,501 |
D/D |
(738) |
336,874 |
|
- |
|
| Gao Hanlin |
Chief Scientific Officer |
• – – |
2022-04-30 |
4 |
D |
$54.88 |
$15,531 |
D/D |
(283) |
856,062 |
|
- |
|
| Kim Paul |
CFO and Treasurer |
• – – |
2022-03-03 |
4 |
S |
$56.31 |
$25,564 |
D/D |
(454) |
155,574 |
|
-4% |
|
| Bolger John C |
Director |
– • – |
2022-03-01 |
4 |
S |
$61.27 |
$115,056 |
D/D |
(1,875) |
2,000 |
|
7% |
|
277 Records found
|
|
Page 5 of 12 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.21 (0.98%) 
